Tumour necrosis factor-α-induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition

Journal of Physiology

Volumn 591, Issue 15, 2013, Pages 3709-3723

  Feng, Yongjia ^a   Teitelbaum, Daniel H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN; ETANERCEPT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOSIN LIGHT CHAIN KINASE; OCCLUDIN; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANNULATION; DOWN REGULATION; DOWNSTREAM PROCESSING; ENTERIC FEEDING; INTESTINE FUNCTION DISORDER; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SMALL INTESTINE MUCOSA; TOTAL PARENTERAL NUTRITION; UPREGULATION;

EID: 84880986819     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.253518     Document Type: Article

References (89)

1. Aijaz S, Balda MS & Matter K (2006). Tight junctions: molecular architecture and function. Int Rev Cytol 248, 261-298.
2. Al-Sadi R, Ye D, Dokladny K & Ma TY (2008). Mechanism of IL-1β-induced increase in intestinal epithelial tight junction permeability. J Immunol 180, 5653-5661.
3. Al-Sadi R, Ye D, Said HM & Ma TY (2010). IL-1β-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-κB pathway. Am J Pathol 177, 2310-2322.
4. Amasheh M, Fromm A, Krug SM, Amasheh S, Andres S, Zeitz M, Fromm M & Schulzke JD (2010). TNFα-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFκB signaling. J Cell Sci 123, 4145-4155.
5. Amasheh M, Grotjohann I, Amasheh S, Fromm A, Söderholm JD, Zeitz M, Fromm M & Schulzke JD (2009). Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines. Scand J Gastroenterol 44, 1226-1235.
6. Amasheh S, Meiri N, Gitter AH, Schöneberg T, Mankertz J, Schulzke JD & Fromm M (2002). Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 115, 4969-4976.
7. Arrieta MC, Madsen K, Doyle J & Meddings J (2009). Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut 58, 41-48.
8. Baert FJ & Rutgeerts PR (1999). Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications. Int J Colorectal Dis 14, 47-51.
9. Baert FJ & Rutgeerts PJ (2000). Medical therapies for ulcerative colitis and Crohn's disease. Curr Gastroenterol Rep 2, 446-450.
10. Barnes PJ & Karin M (1997). Nuclear factor-κB-a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336, 1066-1071.
11. Bereswill S, Muñoz M, Fischer A, Plickert R, Haag LM, Otto B, Kühl AA, Loddenkemper C, Göbel UB & Heimesaat MM (2010). Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One 5, e15099.
12. Brown GR, Lindberg G, Meddings J, Silva M, Beutler B & Thiele D (1999). Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease. Gastroenterology 116, 593-601.
13. Buchman AL, Moukarzel AA, Bhuta S, Belle M, Ament ME, Eckhert CD, Hollander D, Gornbein J, Kopple JD & Vijayaroghavan SR (1995). Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J Parenter Enteral Nutr 19, 453-460.
14. Bücker R, Krug SM, Rosenthal R, Günzel D, Fromm A, Zeitz M, Chakraborty T, Fromm M, Epple HJ & Schulzke JD (2011). Aerolysin from Aeromonas hydrophila perturbs tight junction integrity and cell lesion repair in intestinal epithelial HT-29/B6 cells. J Infect Dis 204, 1283-1292.
15. Chen C, Jamaluddin MS, Yan S, Sheikh-Hamad D & Yao Q (2008). Human stanniocalcin-1 blocks TNF-α-induced monolayer permeability in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 28, 906-912.
16. Chen C, Wang P, Su Q, Wang S & Wang F (2012). Myosin light chain kinase mediates intestinal barrier disruption following burn injury. PLoS One 7, e34946.
17. Clayburgh DR, Barrett TA, Tang Y, Meddings JB, Van Eldik LJ, Watterson DM, Clarke LL, Mrsny RJ & Turner JR (2005). Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest 115, 2702-2715.
18. Clayburgh DR, Musch MW, Leitges M, Fu YX & Turner JR (2006). Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J Clin Invest 116, 2682-2694.
19. Colegio OR, Van Itallie CM, McCrea HJ, Rahner C & Anderson JM (2002). Claudins create charge-selective channels in the paracellular pathway between epithelial cells. Am J Physiol Cell Physiol 283, C142-C147.
20. Cunningham KE & Turner JR (2012). Myosin light chain kinase: pulling the strings of epithelial tight junction function. Ann N Y Acad Sci 1258, 34-42.
21. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E & Karin M (1997). A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388, 548-554.
22. Dull RO, Dinavahi R, Schwartz L, Humphries DE, Berry D, Sasisekharan R & Garcia JG (2003). Lung endothelial heparan sulfates mediate cationic peptide-induced barrier dysfunction: a new role for the glycocalyx. Am J Physiol Lung Cell Mol Physiol 285, L986-L995.
23. Edelblum KL & Turner JR (2009). The tight junction in inflammatory disease: communication breakdown. Curr Opin Pharmacol 9, 715-720.
24. Feng Y, Holst J & Teitelbaum D (2011). Total parenteral nutrition (TPN)-associated atrophy is associated with loss of intestinal epithelial cell (EC) migration: modulation of action by epidermal growth factor (EGF) and glucagon-like peptide-2 (GLP-2). Gastroenterology 140, S-170-S-171.
25. Feng Y, Ralls MW, Xiao W, Miyasaka E, Herman RS & Teitelbaum DH (2012). Loss of enteral nutrition in a mouse model results in intestinal epithelial barrier dysfunction. Ann N Y Acad Sci 1258, 71-77.
26. Feng Y, Sun X, Yang H & Teitelbaum DH (2009). Dissociation of E-cadherin and β-catenin in a mouse model of total parenteral nutrition: a mechanism for the loss of epithelial cell proliferation and villus atrophy. J Physiol 587, 641-654.
27. Feng Y & Teitelbaum DH (2012). Epidermal growth factor/TNF-α transactivation modulates epithelial cell proliferation and apoptosis in a mouse model of parenteral nutrition. Am J Physiol Gastrointest Liver Physiol 302, G236-G249.
28. Fries W, Muja C, Crisafulli C, Costantino G, Longo G, Cuzzocrea S & Mazzon E (2008). Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitis. Int J Med Sci 5, 169-180.
29. Furuse M, Furuse K, Sasaki H & Tsukita S (2001). Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153, 263-272.
30. Ghosh S & Karin M (2002). Missing pieces in the NF-κB puzzle. Cell 109 Suppl, S81-S96.
31. Gilbert S, Zhang R, Denson L, Moriggl R, Steinbrecher K, Shroyer N, Lin J & Han X (2012). Enterocyte STAT5 promotes mucosal wound healing via suppression of myosin light chain kinase-mediated loss of barrier function and inflammation. EMBO Mol Med 4, 109-124.
32. Grossmann J, Maxson J, Whitacre C, Orosz D, Berger N, Fiocchi C & Levine A (1998). New isolation technique to study apoptosis in human intestinal epithelial cells. Am J Pathol 153, 53-62.
33. Gunther C, Martini E, Wittkopf N, Amann K, Weigmann B, Neumann H, Waldner MJ, Hedrick SM, Tenzer S, Neurath MF & Becker C (2011). Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature 477, 335-339.
34. Hagiwara S, Iwasaka H, Kusaka J, Asai N, Uchida T & Noguchi T (2011). Total parenteral-nutrition-mediated dendritic-cell activation and infiltration into the small intestine in a rat model. J Anesth 25, 57-64.
35. HCUPnet (2010). National Center for Health Statistics Data on PN and EN Use. http://hcupnet.ahrq.gov/
36. Hering NA, Andres S, Fromm A, van Tol EA, Amasheh M, Mankertz J, Fromm M & Schulzke JD (2011). Transforming growth factor-β, a whey protein component, strengthens the intestinal barrier by upregulating claudin-4 in HT-29/B6 cells. J Nutr 141, 783-789.
37. Holmes JL, Van Itallie CM, Rasmussen JE & Anderson JM (2006). Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr Patterns 6, 581-588.
38. Itoh M, Nagafuchi A, Moroi S & Tsukita S (1997). Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to α catenin and actin filaments. J Cell Biol 138, 181-192.
39. Jonker MA, Hermsen JL, Sano Y, Heneghan AF, Lan J & Kudsk KA (2012). Small intestine mucosal immune system response to injury and the impact of parenteral nutrition. Surgery 151, 278-286.
40. Kansagra K, Stoll B, Rognerud C, Niinikoski H, Ou CN, Harvey R & Burrin D (2003). Total parenteral nutrition adversely affects gut barrier function in neonatal piglets. Am J Physiol Gastrointest Liver Physiol 285, G1162-G1170.
41. Kiristioglu I & Teitelbaum DH (1998). Alteration of the intestinal intraepithelial lymphocytes during total parenteral nutrition. J Surg Res 79, 91-96.
42. Kisseleva T, Song L, Vorontchikhina M, Feirt N, Kitajewski J & Schindler C (2006). NF-κB regulation of endothelial cell function during LPS-induced toxemia and cancer. J Clin Invest 116, 2955-2963.
43. Kolodziej LE, Lodolce JP, Chang JE, Schneider JR, Grimm WA, Bartulis SJ, Zhu X, Messer JS, Murphy SF, Reddy N, Turner JR & Boone DL (2011). TNFAIP3 maintains intestinal barrier function and supports epithelial cell tight junctions. PLoS One 6, e26352.
44. Lorenzo-Zúñiga V, Rodríguez-Ortigosa CM, Bartolí R, Martínez-Chantar ML, Martínez-Peralta L, Pardo A, Ojanguren I, Quiroga J, Planas R & Prieto J (2006). Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats. Gut 55, 1306-1312.
45. Mankertz J, Amasheh M, Krug SM, Fromm A, Amasheh S, Hillenbrand B, Tavalali S, Fromm M & Schulzke JD (2009). TNFα up-regulates claudin-2 expression in epithelial HT-29/B6 cells via phosphatidylinositol-3-kinase signaling. Cell Tissue Res 336, 67-77.
46. Marchiando AM, Shen L, Graham WV, Edelblum KL, Duckworth CA, Guan Y, Montrose MH, Turner JR & Watson AJ (2011). The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. Gastroenterology 140, 1208-1218, e2.
47. Marchiando AM, Shen L, Graham WV, Weber CR, Schwarz BT, Austin JR 2nd, Raleigh DR, Guan Y, Watson AJ, Montrose MH & Turner JR (2010). Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol 189, 111-126.
48. Marcial MA, Carlson SL & Madara JL (1984). Partitioning of paracellular conductance along the ileal crypt-villus axis: a hypothesis based on structural analysis with detailed consideration of tight junction structure-function relationships. J Membr Biol 80, 59-70.
49. Meddings JB, Sutherland LR & May GR (1994). Intestinal permeability in patients with Crohn's disease. Gut 35, 1675-1676.
50. Menard S, Lebreton C, Schumann M, Matysiak-Budnik T, Dugave C, Bouhnik Y, Malamut G, Cellier C, Allez M, Crenn P, Schulzke JD, Cerf-Bensussan N & Heyman M (2012). Paracellular versus transcellular intestinal permeability to gliadin peptides in active celiac disease. Am J Pathol 180, 608-615.
51. Mitic LL & Anderson JM (1998). Molecular architecture of tight junctions. Annu Rev Physiol 60, 121-142.
52. Mitic LL, Van Itallie CM & Anderson JM (2000). Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol 279, G250-G254.
53. Nemoto H, Konno S, Sugimoto H, Nakazora H, Nomoto N, Murata M, Kitazono H & Fujioka T (2011). Anti-TNF therapy using etanercept suppresses degenerative and inflammatory changes in skeletal muscle of older SJL/J mice. Exp Mol Pathol 90, 264-270.
54. Nose K, Yang H, Sun X, Nose S, Koga H, Feng Y, Miyasaka E & Teitelbaum DH (2010). Glutamine prevents total parenteral nutrition-associated changes to intraepithelial lymphocyte phenotype and function: a potential mechanism for the preservation of epithelial barrier function. J Interferon Cytokine Res 30, 67-80.
55. Noth R, Lange-Grumfeld J, Stüber E, Kruse ML, Ellrichmann M, Häsler R, Hampe J, Bewig B, Rosenstiel P, Schreiber S & Arlt A (2011). Increased intestinal permeability and tight junction disruption by altered expression and localization of occludin in a murine graft versus host disease model. BMC Gastroenterol 11, 109.
56. Petecchia L, Sabatini F, Usai C, Caci E, Varesio L & Rossi GA (2012). Cytokines induce tight junction disassembly in airway cells via an EGFR-dependent MAPK/ERK1/2-pathway. Lab Invest 92, 1140-1148.
57. Reims A, Strandvik B & Sjövall H (2006). Epithelial electrical resistance as a measure of permeability changes in pediatric duodenal biopsies. J Pediatr Gastroenterol Nutr 43, 619-623.
58. Rothwarf DM & Karin M (1999). The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE 1999, RE1.
59. Scharl M, McCole DF, Weber A, Vavricka SR, Frei P, Kellermeier S, Pesch T, Fried M & Rogler G (2011). Protein tyrosine phosphatase N2 regulates TNFα-induced signalling and cytokine secretion in human intestinal epithelial cells. Gut 60, 189-197.
60. Schumann M, Kamel S, Pahlitzsch ML, Lebenheim L, May C, Krauss M, Hummel M, Daum S, Fromm M & Schulzke JD (2012). Defective tight junctions in refractory celiac disease. Ann N Y Acad Sci 1258, 43-51.
61. Schwarz BT, Wang F, Shen L, Clayburgh DR, Su L, Wang Y, Fu YX & Turner JR (2007). LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. Gastroenterology 132, 2383-2394.
62. Shen L (2012). Tight junctions on the move: molecular mechanisms for epithelial barrier regulation. Ann N Y Acad Sci 1258, 9-18.
63. Shen L, Black ED, Witkowski ED, Lencer WI, Guerriero V, Schneeberger EE & Turner JR (2006). Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 119, 2095-2106.
64. Shifflett DE, Clayburgh DR, Koutsouris A, Turner JR & Hecht GA (2005). Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo. Lab Invest 85, 1308-1324.
65. 2+ resorption. Science 285, 103-106.
66. Spring KR (2002). Focus on "Claudins create charge-selective channels in the paracellular pathway between epithelial cells". Am J Physiol Cell Physiol 283, C29-C30.
67. Su L, Shen L, Clayburgh DR, Nalle SC, Sullivan EA, Meddings JB, Abraham C & Turner JR (2009). Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterology 136, 551-563.
68. Suenaert P, Bulteel V, Lemmens L, Noman M, Geypens B, Van Assche G, Geboes K, Ceuppens JL & Rutgeerts P (2002). Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am J Gastroenterol 97, 2000-2004.
69. Sun X, Yang H, Nose K, Nose S, Haxhija EQ, Koga H, Feng Y & Teitelbaum DH (2008). Decline in intestinal mucosal IL-10 expression and decreased intestinal barrier function in a mouse model of total parenteral nutrition. Am J Physiol Gastrointest Liver Physiol 294, G139-G147.
70. Suzuki T, Yoshinaga N & Tanabe S (2011). Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J Biol Chem 286, 31263-31271.
71. Tamion F, Richard V, Lyoumi S, Daveau M, Bonmarchand G, Leroy J, Thuillez C & Lebreton JP (1997). Gut ischemia and mesenteric synthesis of inflammatory cytokines after hemorrhagic or endotoxic shock. Am J Physiol Gastrointest Liver Physiol 273, G314-G321.
72. Tang Y, Clayburgh DR, Mittal N, Goretsky T, Dirisina R, Zhang Z, Kron M, Ivancic D, Katzman RB, Grimm G, Lee G, Fryer J, Nusrat A, Turner JR & Barrett TA (2010). Epithelial NF-κB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation. Am J Pathol 176, 158-167.
73. Taylor CT, Murphy A, Kelleher D & Baird AW (1997). Changes in barrier function of a model intestinal epithelium by intraepithelial lymphocytes require new protein synthesis by epithelial cells. Gut 40, 634-640.
74. Van Itallie C, Rahner C & Anderson JM (2001). Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 107, 1319-1327.
75. Wachtel M, Bolliger MF, Ishihara H, Frei K, Bluethmann H & Gloor SM (2001). Down-regulation of occludin expression in astrocytes by tumour necrosis factor (TNF) is mediated via TNF type-1 receptor and nuclear factor-κB activation. J Neurochem 78, 155-162.
76. Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT & Turner JR (2005). Interferon-γ and tumor necrosis factor-α synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 166, 409-419.
77. Wang F, Schwarz BT, Graham WV, Wang Y, Su L, Clayburgh DR, Abraham C & Turner JR (2006). IFN-γ-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 131, 1153-1163.
78. Watson AJ & Hughes KR (2012). TNF-α-induced intestinal epithelial cell shedding: implications for intestinal barrier function. Ann N Y Acad Sci 1258, 1-8.
79. Weber CR, Raleigh DR, Su L, Shen L, Sullivan EA, Wang Y & Turner JR (2010). Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem 285, 12037-12046.
80. Wildhaber BE, Yang H, Spencer AU, Drongowski RA & Teitelbaum DH (2005). Lack of enteral nutrition-effects on the intestinal immune system. J Surg Res 123, 8-16.
81. Wildhaber BE, Yang H, Tazuke Y & Teitelbaum DH (2003). Gene alteration of intestinal intraepithelial lymphocytes with administration of total parenteral nutrition. J Pediatr Surg 38, 840-843.
82. Yamaoka T, Yan F, Cao H, Hobbs SS, Dise RS, Tong W & Polk DB (2008). Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis. Proc Natl Acad Sci U S A 105, 11772-11777.
83. Yang H, Feng Y, Sun X & Teitelbaum DH (2009). Enteral versus parenteral nutrition: effect on intestinal barrier function. Ann N Y Acad Sci 1165, 338-346.
84. Yang H, Kiristioglu I, Fan Y, Forbush B, Bishop DK, Antony PA, Zhou H & Teitelbaum DH (2002). Interferon-gamma expression by intraepithelial lymphocytes results in a loss of epithelial barrier function in a mouse model of total parenteral nutrition. Ann Surg 236, 226-234.
85. Yang H, Sun X, Haxhija EQ & Teitelbaum DH (2007). Intestinal epithelial cell-derived interleukin-7: a mechanism for the alteration of intraepithelial lymphocytes in a mouse model of total parenteral nutrition. Am J Physiol Gastrointest Liver Physiol 292, G84-G91.
86. Ye D, Guo S, Al-Sadi R & Ma TY (2011). MicroRNA regulation of intestinal epithelial tight junction permeability. Gastroenterology 141, 1323-1333.
87. Ye D, Ma I & Ma TY (2006). Molecular mechanism of tumor necrosis factor-α modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 290, G496-G504.
88. Ye D & Ma TY (2008). Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-α-induced regulation of myosin light chain kinase gene activity. J Cell Mol Med 12, 1331-1346.
89. Zeissig S, Bürgel N, Günzel D, Richter J, Mankertz J, Wahnschaffe U, Kroesen AJ, Zeitz M, Fromm M & Schulzke JD (2007). Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56, 61-72.